Antibodies to fibroblast growth factor and their methods of use

The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally pro...

Full description

Saved in:
Bibliographic Details
Main Authors JEFFERS MICHAEL, BURGESS CATHERINE, SHIMKETS RICHARD A, LICHENSTEIN HENRI, BOLDOG FERENC L, FERNANDES ELMA, PRAYAGA SUDHIRDAS K, YANG MEIJIA, HERRMANN JOHN L, LAROCHELLE WILLIAM J
Format Patent
LanguageEnglish
Published 24.03.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.
Bibliography:Application Number: US20040948588